CEO: Sean Higgins
ExPrimary is developing high-performance instrumentation at a fraction of the cost of existing products and state-of-the-art assay content. The ExPrimary mission is to dramatically increase access to bioanalytical tools across research and diagnostic markets with a specific focus to meet advancing demand in personalized healthcare.
Visit the ExPrimary website to learn more.
